Report Detail

Request for Sample of this report

Pharma & Healthcare COVID-19 Impact on Global Xerostomia (Dry Mouth) Therapeutics, Market Insights and Forecast to 2026

  • RnM4085337
    • |
  • 30 June, 2020
    • |
  • Global
    • |
  • 117 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Xerostomia (Dry Mouth) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Xerostomia (Dry Mouth) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Xerostomia (Dry Mouth) Therapeutics market is segmented into
Salivary Stimulants
Salivary Substitutes
Dentifrices

Segment by Application, the Xerostomia (Dry Mouth) Therapeutics market is segmented into
OTC
Prescription

Regional and Country-level Analysis
The Xerostomia (Dry Mouth) Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Xerostomia (Dry Mouth) Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Xerostomia (Dry Mouth) Therapeutics Market Share Analysis
Xerostomia (Dry Mouth) Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Xerostomia (Dry Mouth) Therapeutics business, the date to enter into the Xerostomia (Dry Mouth) Therapeutics market, Xerostomia (Dry Mouth) Therapeutics product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline plc
Church & Dwight, Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat


1 Study Coverage

  • 1.1 Xerostomia (Dry Mouth) Therapeutics Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Xerostomia (Dry Mouth) Therapeutics Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size Growth Rate by Type
    • 1.4.2 Salivary Stimulants
    • 1.4.3 Salivary Substitutes
    • 1.4.4 Dentifrices
  • 1.5 Market by Application
    • 1.5.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size Growth Rate by Application
    • 1.5.2 OTC
    • 1.5.3 Prescription
  • 1.6 Coronavirus Disease 2019 (Covid-19): Xerostomia (Dry Mouth) Therapeutics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Xerostomia (Dry Mouth) Therapeutics Industry
      • 1.6.1.1 Xerostomia (Dry Mouth) Therapeutics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Xerostomia (Dry Mouth) Therapeutics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Xerostomia (Dry Mouth) Therapeutics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size Estimates and Forecasts
    • 2.1.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue 2015-2026
    • 2.1.2 Global Xerostomia (Dry Mouth) Therapeutics Sales 2015-2026
  • 2.2 Xerostomia (Dry Mouth) Therapeutics Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Xerostomia (Dry Mouth) Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Xerostomia (Dry Mouth) Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Xerostomia (Dry Mouth) Therapeutics Competitor Landscape by Players

  • 3.1 Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturers
    • 3.1.1 Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturers (2015-2020)
    • 3.1.2 Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturers
    • 3.2.1 Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturers (2015-2020)
    • 3.2.2 Xerostomia (Dry Mouth) Therapeutics Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Xerostomia (Dry Mouth) Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Xerostomia (Dry Mouth) Therapeutics Revenue in 2019
    • 3.2.5 Global Xerostomia (Dry Mouth) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Xerostomia (Dry Mouth) Therapeutics Price by Manufacturers
  • 3.4 Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution, Product Types
    • 3.4.1 Xerostomia (Dry Mouth) Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Type
    • 3.4.3 Date of International Manufacturers Enter into Xerostomia (Dry Mouth) Therapeutics Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Type (2015-2020)
    • 4.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2015-2020)
    • 4.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2015-2020)
    • 4.1.3 Xerostomia (Dry Mouth) Therapeutics Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Xerostomia (Dry Mouth) Therapeutics Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Type (2021-2026)
    • 4.2.3 Xerostomia (Dry Mouth) Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Xerostomia (Dry Mouth) Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Application (2015-2020)
    • 5.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Application (2015-2020)
    • 5.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2015-2020)
    • 5.1.3 Xerostomia (Dry Mouth) Therapeutics Price by Application (2015-2020)
  • 5.2 Xerostomia (Dry Mouth) Therapeutics Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Xerostomia (Dry Mouth) Therapeutics Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Xerostomia (Dry Mouth) Therapeutics by Country
    • 6.1.1 North America Xerostomia (Dry Mouth) Therapeutics Sales by Country
    • 6.1.2 North America Xerostomia (Dry Mouth) Therapeutics Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Type
  • 6.3 North America Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Xerostomia (Dry Mouth) Therapeutics by Country
    • 7.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Country
    • 7.1.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Type
  • 7.3 Europe Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Xerostomia (Dry Mouth) Therapeutics by Region
    • 8.1.1 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Sales by Region
    • 8.1.2 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Type
  • 8.3 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Xerostomia (Dry Mouth) Therapeutics by Country
    • 9.1.1 Latin America Xerostomia (Dry Mouth) Therapeutics Sales by Country
    • 9.1.2 Latin America Xerostomia (Dry Mouth) Therapeutics Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Type
  • 9.3 Central & South America Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics by Country
    • 10.1.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales by Country
    • 10.1.2 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Type
  • 10.3 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GlaxoSmithKline plc
    • 11.1.1 GlaxoSmithKline plc Corporation Information
    • 11.1.2 GlaxoSmithKline plc Description, Business Overview and Total Revenue
    • 11.1.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.1.5 GlaxoSmithKline plc Recent Development
  • 11.2 Church & Dwight, Inc.
    • 11.2.1 Church & Dwight, Inc. Corporation Information
    • 11.2.2 Church & Dwight, Inc. Description, Business Overview and Total Revenue
    • 11.2.3 Church & Dwight, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.2.5 Church & Dwight, Inc. Recent Development
  • 11.3 Colgate-Palmolive Company
    • 11.3.1 Colgate-Palmolive Company Corporation Information
    • 11.3.2 Colgate-Palmolive Company Description, Business Overview and Total Revenue
    • 11.3.3 Colgate-Palmolive Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.3.5 Colgate-Palmolive Company Recent Development
  • 11.4 Hikma Pharmaceuticals PLC
    • 11.4.1 Hikma Pharmaceuticals PLC Corporation Information
    • 11.4.2 Hikma Pharmaceuticals PLC Description, Business Overview and Total Revenue
    • 11.4.3 Hikma Pharmaceuticals PLC Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.4.5 Hikma Pharmaceuticals PLC Recent Development
  • 11.5 Pendopharm
    • 11.5.1 Pendopharm Corporation Information
    • 11.5.2 Pendopharm Description, Business Overview and Total Revenue
    • 11.5.3 Pendopharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Pendopharm Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.5.5 Pendopharm Recent Development
  • 11.6 Sun Pharmaceuticals Industries Ltd.
    • 11.6.1 Sun Pharmaceuticals Industries Ltd. Corporation Information
    • 11.6.2 Sun Pharmaceuticals Industries Ltd. Description, Business Overview and Total Revenue
    • 11.6.3 Sun Pharmaceuticals Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.6.5 Sun Pharmaceuticals Industries Ltd. Recent Development
  • 11.7 Lupin Pharmaceuticals, Inc.
    • 11.7.1 Lupin Pharmaceuticals, Inc. Corporation Information
    • 11.7.2 Lupin Pharmaceuticals, Inc. Description, Business Overview and Total Revenue
    • 11.7.3 Lupin Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.7.5 Lupin Pharmaceuticals, Inc. Recent Development
  • 11.8 Pfizer, Inc.
    • 11.8.1 Pfizer, Inc. Corporation Information
    • 11.8.2 Pfizer, Inc. Description, Business Overview and Total Revenue
    • 11.8.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.8.5 Pfizer, Inc. Recent Development
  • 11.9 Parnell Pharmaceuticals, Inc.
    • 11.9.1 Parnell Pharmaceuticals, Inc. Corporation Information
    • 11.9.2 Parnell Pharmaceuticals, Inc. Description, Business Overview and Total Revenue
    • 11.9.3 Parnell Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.9.5 Parnell Pharmaceuticals, Inc. Recent Development
  • 11.10 Acacia Pharma
    • 11.10.1 Acacia Pharma Corporation Information
    • 11.10.2 Acacia Pharma Description, Business Overview and Total Revenue
    • 11.10.3 Acacia Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.10.5 Acacia Pharma Recent Development
  • 11.1 GlaxoSmithKline plc
    • 11.1.1 GlaxoSmithKline plc Corporation Information
    • 11.1.2 GlaxoSmithKline plc Description, Business Overview and Total Revenue
    • 11.1.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Products Offered
    • 11.1.5 GlaxoSmithKline plc Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Xerostomia (Dry Mouth) Therapeutics Market Estimates and Projections by Region
    • 12.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Regions 2021-2026
  • 12.2 North America Xerostomia (Dry Mouth) Therapeutics Market Size Forecast (2021-2026)
    • 12.2.1 North America: Xerostomia (Dry Mouth) Therapeutics Sales Forecast (2021-2026)
    • 12.2.2 North America: Xerostomia (Dry Mouth) Therapeutics Revenue Forecast (2021-2026)
    • 12.2.3 North America: Xerostomia (Dry Mouth) Therapeutics Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Xerostomia (Dry Mouth) Therapeutics Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Xerostomia (Dry Mouth) Therapeutics Sales Forecast (2021-2026)
    • 12.3.2 Europe: Xerostomia (Dry Mouth) Therapeutics Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Xerostomia (Dry Mouth) Therapeutics Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Xerostomia (Dry Mouth) Therapeutics Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Xerostomia (Dry Mouth) Therapeutics Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Xerostomia (Dry Mouth) Therapeutics Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Xerostomia (Dry Mouth) Therapeutics Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Xerostomia (Dry Mouth) Therapeutics Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Xerostomia (Dry Mouth) Therapeutics Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Xerostomia (Dry Mouth) Therapeutics Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Xerostomia (Dry Mouth) Therapeutics Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Xerostomia (Dry Mouth) Therapeutics Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Xerostomia (Dry Mouth) Therapeutics Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Xerostomia (Dry Mouth) Therapeutics Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Xerostomia (Dry Mouth) Therapeutics Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Xerostomia (Dry Mouth) Therapeutics. Industry analysis & Market Report on COVID-19 Impact on Global Xerostomia (Dry Mouth) Therapeutics is a syndicated market report, published as COVID-19 Impact on Global Xerostomia (Dry Mouth) Therapeutics, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Xerostomia (Dry Mouth) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,131.70
    		4,697.55
    		6,263.40
    		3,662.10
    		5,493.15
    		7,324.20
    		602,706.00
    		904,059.00
    		1,205,412.00
    		325,962.00
    		488,943.00
    		651,924.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo